Advent Pharma Ltd. (DSE:ADVENT)
Bangladesh · Delayed Price · Currency is BDT 15.40
-0.20 (-1.28%)
At close: Jul 23, 2026
Advent Pharma Financials Overview
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Revenue Revenue Growth | 458.15 | 500.49 | 571.67 | 558.05 | 530.47 | 503.6 |
Revenue Growth | -4.35% | -12.45% | 2.44% | 5.20% | 5.34% | -5.70% |
Gross Profit Gross Profit Growth | 139.05 | 175.63 | 227.9 | 222.91 | 220.16 | 215.61 |
Operating Income Operating Income Growth | 71.64 | 95.58 | 141.65 | 135.36 | 133.38 | 136.42 |
Net Income Net Income Growth | 48.03 | 66.87 | 83.99 | 98.64 | 97.53 | 113.59 |
Earnings Per Share EPS Growth | 0.52 | 0.72 | 0.90 | 1.06 | 1.05 | 1.22 |
EPS Growth | -0.73% | -20.38% | -14.85% | 1.14% | -14.14% | -2.96% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Investments Cash & Investments Growth | 0.9 | 1.77 | 3.97 | 1.07 | 4.31 | 42.69 |
Total Debt Total Debt Growth | 77.65 | 75.79 | 76.01 | 71.59 | 63.92 | 59.91 |
Net Cash (Debt) Net Cash Growth | -76.75 | -74.03 | -72.04 | -70.52 | -59.61 | -17.22 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.83 | -0.79 | -0.77 | -0.76 | -0.64 | -0.18 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 42.65 | 114.74 | 175.13 | 205.3 | 179.57 | 180.38 |
Capital Expenditures CapEx Growth | -42.4 | -94.18 | -162.06 | -202.73 | -191.13 | -184.06 |
Free Cash Flow Free Cash Flow Growth | 0.25 | 20.56 | 13.08 | 2.56 | -11.56 | -3.67 |
Free Cash Flow Growth | -98.86% | 57.25% | 409.89% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Gross Margin | 30.35% | 35.09% | 39.87% | 39.95% | 41.50% | 42.81% |
Operating Margin | 15.64% | 19.10% | 24.78% | 24.26% | 25.14% | 27.09% |
Pretax Margin | 13.54% | 17.24% | 18.15% | 23.05% | 24.56% | 26.65% |
Profit Margin | 10.48% | 13.36% | 14.69% | 17.68% | 18.39% | 22.56% |
FCF Margin | 0.06% | 4.11% | 2.29% | 0.46% | -2.18% | -0.73% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 27, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.050 | 0.050 | 0.100 | 0.200 | 0.200 | 0.196 |
Dividend Per Share Growth | -50.00% | -50.00% | -50.00% | 0% | 1.99% | - |
Dividend Yield | 0.32% | 0.37% | 0.40% | 0.77% | 0.82% | 0.83% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 27, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | 29.29 | 18.94 | 28.39 | 24.93 | 23.97 | 20.02 |
P/FCF Ratio | 5619.38 | 61.59 | 182.32 | 958.68 | - | - |
PS Ratio | 3.09 | 2.53 | 4.17 | 4.41 | 4.41 | 4.51 |